Atlas Trials

Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product

Clinical trial NCT05349396 · COMPLETED

Trial details

NCT number
NCT05349396
Sponsor
Laboratorios Andromaco S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2022-04-11
Primary completion
2022-04-19
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.